Skip to content

CytoMed Therapeutics Limited

GDTC

CIK 0001873093

← back to feed
Revenue (TTM)
252.27K
+395.9% YoY FY Dec 2025
Net Income (TTM)
−3.11M
−68.4% YoY FY Dec 2025
EPS Diluted (TTM)
−0.27
−68.8% YoY FY Dec 2025
Gross Margin
—
FY Dec 2025
Operating Margin
—
FY Dec 2025
Net Margin
-1,232.0%
FY Dec 2025
Free Cash Flow (TTM)
—
FY Dec 2025
Cash
1.63M
FY Dec 2025
Total Debt
—
FY Dec 2025
Shares Outstanding
11.83M sh
FY Dec 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings